Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Arrowhead Pharmaceuticals (ARWR) Long-Term Debt Repayments (2016 - 2019)

Historic Long-Term Debt Repayments for Arrowhead Pharmaceuticals (ARWR) over the last 10 years, with Q4 2025 value amounting to $66.7 million.

  • Arrowhead Pharmaceuticals' Long-Term Debt Repayments changed N/A to $66.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $66.7 million, marking a year-over-year increase of 4476510000.0%. This contributed to the annual value of $201.6 million for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q4 2025, Arrowhead Pharmaceuticals' Long-Term Debt Repayments is $66.7 million.
  • Arrowhead Pharmaceuticals' Long-Term Debt Repayments' 5-year high stood at $66.7 million during Q4 2025, with a 5-year trough of $66.7 million in Q4 2025.